View of MF-59 Adjuvant vs. Alum in an Inactivated SARS-CoV-2 Vaccine Model: Focusing on Heterologous Antigen-Binding Response

Return to Article Details MF-59 Adjuvant vs. Alum in an Inactivated SARS-CoV-2 Vaccine Model: Focusing on Heterologous Antigen-Binding Response Download Download PDF